Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Sizing Up Bracing For Pediatric Sports Injuries

Pediatrics sports injuries are on the rise. According to Johns Hopkins Medicine, more than 3.5 million children age 14 and younger get hurt annually playing sports or participating in recreational activities.1 And these injuries continue to rise. A Safe Kids Worldwide survey of emergency room visits shows more than a million times a year – roughly…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Pediatrics sports injuries are on the rise. According to Johns Hopkins Medicine, more than 3.5 million children age 14 and younger get hurt annually playing sports or participating in recreational activities.1 And these injuries continue to rise. A Safe Kids Worldwide survey of emergency room visits shows more than a million times a year – roughly every 25 seconds – a young athlete visits a hospital emergency room to treat a sports-related injury.2 The survey found the most common injuries were strains and sprains, followed by fractures, bruises, and scrapes.

Contact sports, such as football, hockey, and soccer, are responsible for some of the more severe injuries. However, all sports have a potential for injury, whether from the trauma of contact with other players or from overuse or misuse of a body part. Even more serious injuries may occur during non-contact sports such as swimming, bicycling, and softball, and recreational activities such as in-line skating, skateboarding, sledding, and trampolines.3

Despite the increasing trends in sports injuries, few devices used to treat these injuries, such as splints and braces, have been developed specifically for children mostly due to the lack of incentives to support device development.4 The pediatric market is much smaller when compared to adults resulting in a lower return on investment for medical device manufacturers.

The right fit, not just a smaller size

AliMed recognizes that children have distinct needs, which is why we developed our FREEDOM line of pediatric bracing. Comfortable, durable, and sized to fit properly, our braces are designed specifically to support the growing needs of children while helping to foster compliance for better patient outcomes. Choose the right fit, not just a smaller size.

Pediatric Elbow Sleeves: For lateral ligament sprains, strains, bursitis, tendonitis. Adjustable hook-and-loop top closure adjusts to accommodate smaller arms.

Pediatric Wrist Supports: For treatment of wrist strains and sprains. Adjustable circumferential strap provides compression for wrist immobilization.

Pediatric Ankle Supports: Ideal for ligament sprains and protective and post-operative support for smaller ankles.

Premium Knee Braces: For ACL/PCL injuries, these braces combine the support of a knee sleeve with an adjustable wraparound top to accommodate varying calf and thigh widths.

Read more at alimed.com

REFERENCES

  1. https://www.hopkinsmedicine.org/healthlibrary/conditions/pediatrics/sports_injury_statistics_90,P02787
  2. https://www.cbsnews.com/news/study-kids-hurt-during-sports-once-every-25-seconds/
  3. https://www.hopkinsmedicine.org/healthlibrary/conditions/pediatrics/sports_injury_statistics_90,P02787
  4. http://pediatrics.aappublications.org/content/139/1/e20163439
  5. http://pediatrics.aappublications.org/content/133/5/e1197
  6. https://scopeblog.stanford.edu/2018/06/25/pediatric-medical-device-approvals-need-to-speed-up-says-fda-specialist/
  7. https://www.mpo-mag.com/issues/2014-04-01/view_features/pediatric-medical-devices-little-world-lost

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512